H-Index
38
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST

Logo

MSMbanner
Medical Science Monitor Basic Research

AmJCaseRep
MedSciTechnol

eISSN: 2329-0358

Get your full text copy in PDF

Cytokine Profilesas Marker for Graft Vascular Disease after Clinical Heart Transplantation

Nicole M van Besouw, Carla C Baan, Cecile T T Holweg, Hester A de Groot-Krnseman, Annemiek M A Peeters, Aggie H M M Balk, Willem Weimar

Ann Transplant 2000; 5(2): 61-67

ID: 497528


The efficacy of heart transplantation for end-stage cardiac disease is generally accepted. Patient survival rates after 1, 5 and 10 years are about 90%, 80% and 50%, respectively [1] but its long-term success is limited by chronic rejection. Chronic rejection results in graft coronary artery occlusive disease which in turns leads to ischemia and organ destruction. In human heart transplants it is characterised by a process of accelerated coronary artery disease, also called graft vascular disease (GVD). This type of rejection is represented by concentric intimal thickening of the entire length of the coronary vessels.

Keywords: graft vascular disease, Heart Transplantation, Cytokines

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree